LOGO
LOGO

Intraday Alerts

Vericel Stock Slips, Despite 52% Growth In Q4 Profit

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Vericel Corp. (VCEL) Thursday reported a significant growth in fourth quarter earnings, as revenues increased from the prior year.

The company confirmed 2025 financial guidance with a total revenue growth of 20 to 23 percent.

In the pre-market hours shares are at $50.35, down 4.73 percent.

The quarterly net profit was $19.81 million or $0.38 per share, compared to $12.99 million or $0.26 per share last year.

Revenue for the quarter increased 16 percent to $75.38 million from $64.99 million a year ago.

Looking ahead to the full year 2025, the company expects gross margin to be 73 to 74 percent and the adjusted EBITDA margin to be 25 to 26 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Pharma Stocks by Subscribing to RTT Biotech Investor.
Global Economics Weekly Update -June 15 - June 19, 2026

June 19, 2026 16:46 ET
Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.